Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Zen Rating | Growth | Market Cap | Revenue | EBITDA | Earnings | EPS | Rev. Y/Y | Rev. 5Y | Earn. Y/Y | Earn. 5Y | Earnings Date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RAPP | RAPPORT THERAPEUTICS INC | $1.94B | $20.00M | -$133.89M | -$137.16M | -$3.03 | N/A | N/A | N/A | N/A | 2026-11-05 | ||
| GLUE | MONTE ROSA THERAPEUTICS INC | $1.03B | $28.73M | -$155.85M | -$161.12M | -$1.76 | -83.86% | N/A | N/A | N/A | 2026-11-05 | ||
| BLSM | BLOSSOMHILL THERAPEUTICS INC | $818.14M | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| AVTX | AVALO THERAPEUTICS INC | $888.65M | $59.00k | -$100.05M | -$100.33M | -$4.37 | -86.62% | -60.88% | N/A | N/A | 2026-11-05 | ||
| AHCO | ADAPTHEALTH CORP | $778.53M | $3.23B | $338.51M | -$228.23M | -$1.68 | 4.17% | 13.25% | N/A | N/A | 2026-11-03 | ||
| STTK | SHATTUCK LABS INC | $603.18M | $1.00M | -$49.16M | -$52.57M | -$0.47 | -66.63% | -11.25% | N/A | N/A | 2026-11-05 | ||
| IFRX | INFLARX NV | $308.00M | -$11.64k | -$44.59M | -$45.10M | -$0.58 | N/A | N/A | N/A | N/A | 2026-11-09 | ||
| PPLI | PEOPLE INC | $2.69B | $2.10B | $806.24M | $336.30M | $5.59 | -8.43% | -7.50% | N/A | -16.83% | 2026-11-02 | ||
| SABS | SAB BIOTHERAPEUTICS INC | $319.36M | $0.00 | -$9.43M | -$12.78M | -$0.64 | -100.00% | -100.00% | N/A | N/A | |||
| GUTS | FRACTYL HEALTH INC | $95.51M | $0.00 | -$102.85M | -$105.65M | -$0.88 | -100.00% | N/A | N/A | N/A | 2026-11-11 | ||
| RLMD | RELMADA THERAPEUTICS INC | $439.48M | $0.00 | -$61.93M | -$61.93M | -$0.92 | N/A | N/A | N/A | N/A | 2026-11-12 | ||
| AADX | APPLIED AEROSPACE & DEFENSE INC | $2.20B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 2026-11-11 | ||
| IMUX | IMMUNIC INC | $144.90M | $0.00 | -$110.67M | -$111.57M | -$3.88 | N/A | N/A | N/A | N/A | 2026-11-12 | ||
| SCTX | SCRIBE THERAPEUTICS INC | $624.75M | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| MSTR | STRATEGY INC | $59.14B | $498.35M | -$36.20B | -$31.37B | -$99.46 | 7.79% | -0.34% | N/A | N/A | 2026-10-29 | ||
| TFII | TFI INTERNATIONAL INC | $10.29B | $8.12B | $1.20B | $335.80M | $4.09 | -1.72% | 10.00% | -6.62% | -10.14% | 2026-10-29 | ||
| ASMB | ASSEMBLY BIOSCIENCES INC | $508.40M | $0.00 | $68.00k | -$42.00k | $1.02 | N/A | -100.00% | N/A | N/A | 2026-11-09 | ||
| ELTX | ELICIO THERAPEUTICS INC | $49.67M | $0.00 | -$35.12M | -$37.84M | -$2.17 | N/A | -100.00% | N/A | N/A | 2026-11-12 | ||
| TRAX | FIRST TRACKS BIOTHERAPEUTICS INC | $1.38B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 2026-11-11 | ||
| PAC | PACIFIC AIRPORT GROUP | $10.25B | $2.32B | $1.23B | $535.56M | $10.60 | 42.54% | 30.99% | 28.51% | 41.06% | 2026-10-19 | ||
| DSGX | DESCARTES SYSTEMS GROUP INC | $6.64B | $775.17M | $337.45M | $188.01M | $2.18 | 13.20% | 15.06% | 26.01% | 20.45% | |||
| XNCR | XENCOR INC | $1.84B | $104.97M | -$123.60M | -$163.33M | -$2.17 | -28.56% | -10.09% | N/A | N/A | 2026-11-04 | ||
| AKBA | AKEBIA THERAPEUTICS INC | $253.83M | $219.06M | -$10.04M | -$29.67M | -$0.11 | 7.52% | -0.20% | N/A | N/A | 2026-11-09 | ||
| ECHO | ECHOSTAR CORP | $27.15B | $14.65B | -$5.60B | -$5.67B | -$19.87 | -5.17% | 49.76% | N/A | N/A | 2026-11-05 | ||
| GIII | G III APPAREL GROUP LTD | $1.18B | $2.85B | $264.72M | $135.40M | $3.24 | -8.74% | 3.88% | -22.30% | 4.82% | |||
| PCOR | PROCORE TECHNOLOGIES INC | $7.79B | $1.42B | $83.26M | -$38.88M | -$0.26 | 15.41% | 25.99% | N/A | N/A | 2026-11-04 | ||
| LONA | LEONABIO INC | $63.97M | $0.00 | -$140.22M | -$141.46M | -$23.11 | N/A | N/A | N/A | N/A | 2026-11-05 | ||
| WVE | WAVE LIFE SCIENCES INC | $857.16M | $65.37M | -$193.31M | -$202.47M | -$1.08 | -30.42% | 33.07% | N/A | N/A | 2026-11-09 | ||
| IMMX | IMMIX BIOPHARMA INC | $894.24M | $0.00 | -$39.40M | -$39.92M | -$0.88 | N/A | N/A | N/A | N/A | 2026-11-06 | ||
| SKHY | SK HYNIX INC | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| NKTR | NEKTAR THERAPEUTICS | $2.29B | $54.59M | -$125.41M | -$157.13M | -$6.51 | -27.15% | -12.34% | N/A | N/A | 2026-11-05 | ||
| SPRB | SPRUCE BIOSCIENCES INC | $152.47M | $0.00 | -$48.39M | -$51.35M | -$39.78 | -100.00% | N/A | N/A | N/A | 2026-11-09 | ||
| CABA | CABALETTA BIO INC | $432.34M | $0.00 | -$159.94M | -$181.32M | -$1.52 | N/A | N/A | N/A | N/A | 2026-11-09 | ||
| JMKE | JERSEY MIKE's SUBS INC | $6.22B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| AGMB | AGOMAB THERAPEUTICS NV | $593.13M | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| IRON | DISC MEDICINE INC | $2.67B | $0.00 | -$241.17M | -$245.89M | -$6.58 | N/A | N/A | N/A | N/A | 2026-11-05 | ||
| ARWR | ARROWHEAD PHARMACEUTICALS INC | $9.39B | $669.50M | -$181.49M | -$319.95M | -$2.25 | 16.85% | 44.13% | N/A | N/A | |||
| LTRX | LANTRONIX INC | $273.23M | $120.90M | -$872.00k | -$4.18M | -$0.10 | -1.65% | 11.08% | N/A | N/A | 2026-11-04 | ||
| TLX | TELIX PHARMACEUTICALS LTD | $4.28B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| SRRK | SCHOLAR ROCK HOLDING CORP | $5.68B | $0.00 | -$390.64M | -$408.59M | -$3.32 | N/A | -100.00% | N/A | N/A | |||
| BRSP | BRIGHTSPIRE CAPITAL INC | $525.08M | $204.42M | $25.70M | -$26.86M | -$0.24 | 4.70% | -2.43% | N/A | N/A | 2026-10-27 | ||
| ARVN | ARVINAS INC | $542.05M | $316.70M | $14.90M | $9.30M | $0.27 | -15.05% | 66.28% | N/A | N/A | 2026-11-04 | ||
| INFQ | INFLEQTION INC | $2.98B | $55.46M | -$83.09M | -$88.71M | -$1.16 | 30.76% | N/A | N/A | N/A | 2026-11-11 | ||
| ACRS | ACLARIS THERAPEUTICS INC | $809.59M | $8.22M | -$75.32M | -$75.74M | -$0.58 | -51.05% | 4.39% | N/A | N/A | 2026-11-05 | ||
| ADTN | ADTRAN HOLDINGS INC | $586.67M | $1.14B | $97.52M | -$26.08M | -$0.28 | 15.75% | 16.34% | N/A | N/A | 2026-11-02 | ||
| TSM | TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD | $2.25T | $138.75B | $105.27B | $69.27B | $13.36 | 19.70% | 21.75% | 40.62% | 28.81% | 2026-10-15 | ||
| CNTX | CONTEXT THERAPEUTICS INC | $33.81M | $0.00 | -$45.81M | -$45.96M | -$0.48 | N/A | N/A | N/A | N/A | 2026-11-04 | ||
| ATHE | ALTERITY THERAPEUTICS LTD | $70.59M | $2.59M | -$16.68M | -$16.76M | -$0.96 | -50.37% | -5.85% | N/A | N/A | |||
| BTGO | BITGO HOLDINGS INC | $888.64M | $20.07B | -$109.10M | -$95.75M | -$1.19 | 226.70% | N/A | N/A | N/A | 2026-11-11 | ||
| VKTX | VIKING THERAPEUTICS INC | $3.38B | $0.00 | -$534.35M | -$534.80M | -$4.67 | N/A | N/A | N/A | N/A | 2026-10-28 | ||
| SEPN | SEPTERNA INC | $1.81B | $98.88M | -$19.06M | -$24.24M | -$0.54 | 13,520.11% | N/A | N/A | N/A | 2026-11-09 | ||
| SGRY | SURGERY PARTNERS INC | $1.73B | $3.37B | $429.10M | -$88.60M | -$0.69 | 3.99% | 9.90% | N/A | N/A | 2026-11-09 | ||
| COAG | HEMAB THERAPEUTICS HOLDINGS INC | $1.92B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 2026-11-10 | ||
| GENB | GENERATE BIOMEDICINES INC | $2.20B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 2026-11-05 | ||
| ZGN | ERMENEGILDO ZEGNA NV | $3.30B | $2.30B | $538.49M | $144.33M | N/A | 0.19% | 9.37% | N/A | N/A | |||
| BWAY | BRAINSWAY LTD | $533.05M | $60.70M | $13.54M | $9.44M | $0.25 | 31.71% | 18.29% | 66.67% | N/A | 2026-11-10 | ||
| ABVX | ABIVAX SA | $8.29B | $5.79M | -$249.95M | -$390.82M | -$5.28 | -57.55% | N/A | N/A | N/A | 2026-09-21 | ||
| ELAN | ELANCO ANIMAL HEALTH INC | $11.20B | $5.02B | $775.00M | -$199.00M | -$0.41 | 11.95% | 1.99% | N/A | N/A | 2026-11-06 | ||
| TYRA | TYRA BIOSCIENCES INC | $1.54B | $0.00 | -$148.03M | -$148.57M | -$2.39 | N/A | N/A | N/A | N/A | 2026-11-04 | ||
| NKTX | NKARTA INC | $202.70M | $0.00 | -$105.57M | -$117.32M | -$1.57 | N/A | N/A | N/A | N/A | 2026-11-09 | ||
| ZNTL | ZENTALIS PHARMACEUTICALS INC | $222.90M | $0.00 | -$138.22M | -$139.55M | -$1.95 | N/A | N/A | N/A | N/A | 2026-11-09 | ||
| AKTS | AKTIS ONCOLOGY INC | $1.22B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 2026-11-12 | ||
| VCYT | VERACYTE INC | $3.20B | $561.90M | $139.68M | $114.48M | $1.44 | 17.28% | 28.97% | 311.43% | N/A | 2026-11-03 | ||
| LTM | LATAM AIRLINES GROUP SA | $29.37B | $14.27B | $2.34B | $1.46B | $4.95 | 11.16% | 29.45% | 53.28% | N/A | |||
| NEXN | NEXXEN INTERNATIONAL LTD | $253.90M | $382.86M | $90.99M | $13.07M | $0.44 | 2.99% | 5.71% | -70.27% | -14.59% | 2026-11-12 | ||
| CEVA | CEVA INC | $852.22M | $115.73M | -$37.00k | -$10.98M | -$0.40 | 8.82% | 1.21% | N/A | N/A | 2026-11-09 | ||
| SLDB | SOLID BIOSCIENCES INC | $955.38M | $0.00 | -$203.08M | -$207.10M | -$1.91 | N/A | -100.00% | N/A | N/A | 2026-11-02 | ||
| QNT | QUANTINUUM INC | $13.58B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 2026-11-10 | ||
| OMAB | CENTRAL NORTH AIRPORT GROUP | $4.70B | $918.55M | $573.15M | $307.35M | $6.37 | 22.56% | 26.87% | 25.39% | 40.38% | 2026-10-22 | ||
| CRVO | CERVOMED INC | $36.74M | $331.30k | -$30.35M | -$30.35M | -$3.22 | -95.74% | N/A | N/A | N/A | 2026-11-06 | ||
| CX | CEMEX SAB DE CV | $14.59B | $16.13B | $3.09B | $960.00M | $0.22 | 0.43% | 4.95% | 1.84% | N/A | 2026-10-26 | ||
| CGEM | CULLINAN THERAPEUTICS INC | $1.36B | $0.00 | -$204.37M | -$205.35M | -$3.11 | N/A | -100.00% | N/A | N/A | 2026-11-05 | ||
| FDMT | 4D MOLECULAR THERAPEUTICS INC | $840.82M | $92.01M | -$171.05M | -$179.18M | -$2.63 | 278,712.12% | 31.93% | N/A | N/A | 2026-11-09 | ||
| XNDU | XANADU QUANTUM TECHNOLOGIES LTD | $2.26B | $7.21M | -$97.92M | -$105.98M | -$9.17 | 144.32% | N/A | N/A | N/A | 2026-11-04 | ||
| JHX | JAMES HARDIE INDUSTRIES PLC | $14.99B | $5.41B | $1.18B | $145.70M | $0.25 | 42.93% | 11.60% | -67.53% | -21.52% | |||
| PAAS | PAN AMERICAN SILVER CORP | $21.07B | $3.13B | $1.79B | $930.05M | $3.32 | 36.14% | 16.17% | 128.97% | 18.68% | 2026-11-11 | ||
| MSLE | SATELLOS BIOSCIENCE INC | $194.21M | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| HELP | CYBIN INC | $766.74M | $0.00 | -$123.35M | -$123.43M | -$2.99 | N/A | N/A | N/A | N/A | 2026-11-12 | ||
| KLRA | KAILERA THERAPEUTICS INC | $1.66B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 2026-11-11 | ||
| BLND | BLEND LABS INC | $281.45M | $129.97M | $5.54M | -$19.37M | -$0.08 | 6.80% | 1.20% | N/A | N/A | 2026-11-05 | ||
| SGMT | SAGIMET BIOSCIENCES INC | $689.34M | $0.00 | -$46.93M | -$47.08M | -$1.29 | N/A | N/A | N/A | N/A | 2026-11-12 | ||
| CRBP | CORBUS PHARMACEUTICALS HOLDINGS INC | $144.67M | $0.00 | -$101.70M | -$101.90M | -$6.11 | N/A | -100.00% | N/A | N/A | 2026-11-11 | ||
| ATOS | ATOSSA THERAPEUTICS INC | $22.15M | $0.00 | -$37.69M | -$37.71M | -$4.45 | N/A | N/A | N/A | N/A | 2026-11-11 | ||
| OLMA | OLEMA PHARMACEUTICALS INC | $859.23M | $0.00 | -$202.91M | -$204.57M | -$2.13 | N/A | N/A | N/A | N/A | 2026-11-09 | ||
| FTH | FAETH THERAPEUTICS INC | $891.49M | $0.00 | -$193.89M | -$195.53M | -$141.65 | N/A | N/A | N/A | N/A | |||
| MBX | MBX BIOSCIENCES INC | $3.03B | $0.00 | -$103.82M | -$104.29M | -$2.36 | N/A | N/A | N/A | N/A | 2026-11-05 | ||
| NVCT | NUVECTIS PHARMA INC | $716.79M | $0.00 | -$27.85M | -$30.28M | -$1.31 | N/A | N/A | N/A | N/A | 2026-11-03 | ||
| OSTX | OS THERAPIES INC | $81.64M | $0.00 | -$38.79M | -$39.37M | -$1.09 | N/A | N/A | N/A | N/A | |||
| KARD | KARDIGAN INC | $1.56B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 2026-11-10 | ||
| WHWK | WHITEHAWK THERAPEUTICS INC | $239.44M | $0.00 | -$79.82M | -$79.83M | -$1.15 | -100.00% | -100.00% | N/A | N/A | 2026-11-05 | ||
| BNTX | BIONTECH SE | $24.29B | $3.01B | -$1.03B | -$1.92B | -$7.63 | -11.07% | -20.10% | N/A | N/A | 2026-11-02 | ||
| HIVE | HIVE DIGITAL TECHNOLOGIES LTD | $935.29M | $331.30M | -$112.88M | -$327.76M | -$1.32 | 157.52% | 27.05% | N/A | N/A |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.